
Sign up to save your podcasts
Or


Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
By The Motley Fool4.7
16041,604 ratings
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)

3,222 Listeners

1,502 Listeners

806 Listeners

948 Listeners

518 Listeners

1,183 Listeners

2,172 Listeners

826 Listeners

1,416 Listeners

1,038 Listeners

9,627 Listeners

194 Listeners

811 Listeners

76 Listeners

38 Listeners

999 Listeners

44 Listeners